Domov › Rak endometrija › Missouri › St. Louis
Klinične študije za Rak endometrija v St. Louis, MO
29 študij za Rak endometrija išče udeležence na lokacijah v St. Louis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Vključevanje udeležencevFaza 3
- Washington University School of Medicine, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi stran
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi stran
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- in še 6
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Washington University Medicine, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Washington University, School of Medicine, St Louis
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Vključevanje udeležencevFaza 2
- Washington University School of Medicine, St Louis
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Research Site, St Louis
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Vključevanje udeležencevFaza 2
- Washington University School of Medicine, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Vključevanje udeležencevFaza 1
- Washington University, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Vključevanje udeležencevFaza 1/2
- Washington Univ. School of Medicine, St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Research Site, St Louis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Vključevanje udeležencevFaza 3
- Washington University School of Medicine, St Louis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Vključevanje udeležencevFaza 3
- Research Site, St Louis
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Vključevanje udeležencevFaza 1/2
- Washington University School of Medicine, St Louis
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Washington University, Siteman Cancer Center, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Vključevanje udeležencevFaza 1
- Normunity Investigational Site, St Louis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Washington University, St Louis
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Investigative Site #110, St Louis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Vključevanje udeležencevFaza 2
- 521, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Washington University, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Vključevanje udeležencevOpazovalna študija
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- Washington University, St Louis
Uterine Preservation Via Lifestyle Transformation
Vključevanje udeležencevFaza 2
- Washington University School of Medicine, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Washington University Medical Campus, St Louis
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Vključevanje udeležencevFaza 1
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, St Louis
Mindfulness in Endometrial and Cervical Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Saint Louis University, St Louis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Vključevanje udeležencevFaza 2/3
- Washington University School of Medicine, St Louis
Študije za Rak endometrija v drugih mestih
- Houston, TX68 študij
- New York City, NY52 študij
- Boston, MA50 študij
- Arlington, VA39 študij
- Nashville, TN38 študij
- Los Angeles, CA34 študij
- Philadelphia, PA28 študij
- San Antonio, TX27 študij
- Columbus, OH25 študij
- Oklahoma City, OK25 študij
- Chicago, IL25 študij
- Queens, NY25 študij
Druge študije v St. Louis
- Nemalicelični pljučni rak73 študij
- Rak dojke64 študij
- Metastatski rak54 študij
- Kolorektalni rak50 študij
- Rak (vse vrste)46 študij
- Rak prostate46 študij
- Rak pljuč39 študij
- Rak jajčnikov38 študij
- Rak trebušne slinavke33 študij
- Ploščatocelični karcinom glave in vratu28 študij
- Srčno popuščanje26 študij
- Debelost25 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.